Leuprolide
Common brands: Eligard, Lupron Depot, Lupron Depot-Ped, Fensolvi, Leuprolide Acetate Depot
Top reporter: Tolmar Inc.
Androgen Receptor Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Provitamin D2 Compound [EPC]Platelet Aggregation Inhibitor [EPC]
76,176
Total Reports
43,539
Serious Reports
11,797
Death Reports
30
Reported Reactions
Death Report Ratio: High (15.49%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Leuprolide.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | HOT FLUSH | 9,522 | |
| 2 | INTERCEPTED PRODUCT PREPARATION ERROR | 9,058 | |
| 3 | DEATH | 8,335 | |
| 4 | SYRINGE ISSUE | 7,884 | |
| 5 | DEVICE LEAKAGE | 6,123 | |
| 6 | WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 5,334 | |
| 7 | FATIGUE | 5,046 | |
| 8 | INJECTION SITE PAIN | 4,848 | |
| 9 | PROSTATIC SPECIFIC ANTIGEN INCREASED | 2,407 | |
| 10 | ASTHENIA | 2,363 | |
| 11 | OFF LABEL USE | 2,280 | |
| 12 | DRUG INEFFECTIVE | 2,263 | |
| 13 | FALL | 1,963 | |
| 14 | ARTHRALGIA | 1,945 | |
| 15 | PAIN | 1,915 | |
| 16 | HEADACHE | 1,884 | |
| 17 | PROSTATE CANCER | 1,801 | |
| 18 | WEIGHT INCREASED | 1,788 | |
| 19 | DIZZINESS | 1,753 | |
| 20 | NAUSEA | 1,708 | |
| 21 | INTENTIONAL PRODUCT USE ISSUE | 1,661 | |
| 22 | BACK PAIN | 1,403 | |
| 23 | INJECTION SITE MASS | 1,357 | |
| 24 | INSOMNIA | 1,212 | |
| 25 | PAIN IN EXTREMITY | 1,179 | |
| 26 | ABDOMINAL PAIN | 1,164 | |
| 27 | WEIGHT DECREASED | 1,157 | |
| 28 | DYSPNOEA | 1,134 | |
| 29 | INTERCEPTED MEDICATION ERROR | 1,129 | |
| 30 | MALAISE | 1,071 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.